Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona’s ZEVASKYN™ (prademagene zamikeracel) is the first and only autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). Abeona’s fully integrated cell and gene therapy cGMP manufacturing facility in Cleveland, Ohio serves as the manufacturing site for ZEVASKYN commercial production. The Company’s development portfolio features adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need. Abeona’s novel, next-generation AAV capsids are being evaluated to improve tropism profiles for a variety of devastating diseases.
| Website | http://www.abeonatherapeutics.com |
| Ticker | ABEO |
| Revenue | $837000 |
| Employees | 225 (162 on RocketReach) |
| Founded | 2015 |
| Address | 6555 Carnegie Avenue, Cleveland, Ohio 44103, US |
| Phone | (646) 813-4701 |
| Technologies |
HTML
,
PHP
,
Twitter
+24 more
(view full list)
|
| Industry | Biotechnology, Gene Therapy, Biotechnology Research, Business Services General, Drug Discovery, Business Services, Human-derived plasma proteins, Pharma, Alpha-1 deficiency, IVIG, Ultra orphan proteins, Rare Disease, Sanfiippo Syndrome Type A, Sanfiippo Syndrome Type B, MPS IIIA, Juvenile Batten Disease, Fanconi anemia |
| Web Rank | 3 Million |
| Keywords | Abeona Therapeutics, Abeona, Aboena, Abeona Therapeutics Pipeline, Eb-101 |
| Competitors | Novartis, Regeneron, GSK, Audentes Therapeutics, CRISPR Therapeutics, Sangamo Therapeutics, Inc., Spark Therapeutics, Inc., bluebird bio, Precision BioSciences, Inc., UNICURE USA, INC. +47 more (view full list) |
| SIC | SIC Code 37 Companies, SIC Code 376 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 541711 Companies, NAICS Code 54 Companies, NAICS Code 33 Companies, NAICS Code 54171 Companies |
Looking for a particular Abeona Therapeutics employee's phone or email?
Abeona Therapeutics Questions
The Abeona Therapeutics annual revenue was $837000 in 2026.
Vishwas Seshadri is the President and CEO of Abeona Therapeutics.
162 people are employed at Abeona Therapeutics.
Abeona Therapeutics is based in Cleveland, Ohio.
The NAICS codes for Abeona Therapeutics are [541, 5417, 541711, 54, 33, 54171].
The SIC codes for Abeona Therapeutics are [37, 376, 28].
Top Abeona Therapeutics Employees
-
25
-
Joe Vazzano
Chief Financial Officer at Abeona Therapeutics
Morristown, NJ, US35+ -
Alison Hardgrove
Chief People Officer at Abeona Therapeutics
New York, NY, US35+ -
Mohamad Tabrizi
CBO at Abeona Therapeutics
Palo Alto, CA, US35 -
Charlotte Chambers
CEO at Abeona Therapeutics
Marietta, GA, US25+ -
Megan Callan
Vice President of Quality at Abeona Therapeutics
Chagrin Falls, OH, US25 -
William White
Vice President of Market Access at Abeona Therapeutics
Scottsdale, AZ, US11
Related Companies
